| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
6,414 |
451 |
$1.25M |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
2,867 |
120 |
$507K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
1,862 |
129 |
$333K |
| A4657 |
Syringe, with or without needle, each |
584 |
231 |
$143K |
| J1756 |
Injection, iron sucrose, 1 mg |
624 |
93 |
$82K |
| 83970 |
|
54 |
40 |
$11K |
| 85048 |
|
64 |
40 |
$9K |
| 85041 |
|
64 |
40 |
$9K |
| 83540 |
|
38 |
26 |
$7K |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
27 |
14 |
$7K |
| 82728 |
|
20 |
13 |
$3K |
| 83550 |
|
18 |
12 |
$3K |